Sign in Pull a receipt

PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

$272.50 sample

+1.18 (+0.43%) 1D

Market cap

$1.27T

Price as of

2026-10-29

Latest filing

8-K

Alerts

8

Price$272.50 +6.18% 3M daily closessample

281.08256.64

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider buy: General Counsel
Oct 21INSInsider sell: EVP, Operations
Oct 12INSInsider sell: General Counsel
Oct 07INSInsider buy: 10% owner
Sep 30INSInsider sell: Director
Sep 23INSInsider buy: Chief Executive Officer
Sep 14INSInsider sell: 10% owner
Sep 08INSInsider sell: Chief Executive Officer

Sign up to see the real PBLS record →

Company facts

SEC EDGAR registration

Name: Parabilis Medicines, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +20sample, -100 to +100
Reporting currency: USD

Who is positioning in PBLS

sample

Insiders: 22 insider transactions over 90 days, net selling, $159.1M
Congress: 4 members traded over 90 days
Institutions · 13F: 16 funds hold $16.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$50.4B +16.0% y/y

Q4 2024Q3 2026

Inventory$30.9B +19.4% y/y

Q4 2024Q3 2026

Accounts receivable$22.8B +12.0% y/y

Q4 2024Q3 2026

Total debt$58.3B +10.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $210.9B -13.4% 3M
Sample peer B: $755.4B +8.5% 3M
Sample peer C: $1.04T +11.8% 3M
Sample peer D: $398.1B +3.8% 3M
Sample peer E: $303.8B +13.7% 3M